Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT05824039Not ApplicableCompleted

Safety and Efficacy of Medicinal Plant Extract in Overweight and Obese Participants.

Role: collaborator

NCT04988958Completed

Radical Versus Conservative Surgical Treatment of Liver Hydatid Cysts

Role: lead

NCT04843670Completed

Isolated Pancreatic Loop With Modified Pancreaticojejunostomy

Role: lead

NCT04798937Not ApplicableCompleted

Motivational Interviewing to Improve Self Management in Youth With Type 1 Diabetes

Role: lead

NCT04709718Completed

Surgical Management of Giant Hepatic Hemangioma

Role: lead

NCT04649970Completed

Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive Uropathy

Role: lead

NCT04269941Completed

Prognostic Factors Affecting Survival of Gastric GIST

Role: lead

NCT04219176Completed

Spectral Optical Coherence Tomography Findings in Patients With Ocular Toxoplasmosis

Role: lead

All 8 trials loaded